Search For "sufficient worldwide supply"
Gilead Sciences to start trials of inhaled version of remdesivir
Updated : 5 years, 11 months ago IST
California [USA], June 23 (ANI): US-based biopharmaceutical major Gilead Sciences will soon start clinical trials for inhaled formulation of its anti-viral drug remdesivir used for the treatment of Covid-19.
Read More